Related Experiment Videos
[Association between the TPH2 gene and suicidal behavior].
1Uniwersytet Medyczny w Łodzi, Klinika Psychiatrii Doroslych. ann.kamrowska@poczta.onet.pl
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|February 26, 2008
Summary
The Tryptophan hydroxylase (TPH) gene and serotonin pathway are linked to depression and suicidal behavior. Genetic variations may influence treatment effectiveness, but research findings vary.
Area of Science:
- Neurogenetics
- Biochemistry
- Psychiatry
Context:
- Serotonin, a key neurotransmitter, is synthesized from tryptophan.
- The Tryptophan hydroxylase (TPH) gene plays a crucial role in serotonin production.
- Genetic variations in TPH and serotonin transporter genes are implicated in mood disorders.
Purpose:
- To explore the genetic basis of serotonin metabolism and its connection to mental health conditions.
- To analyze the role of TPH gene variants in depressive disorders and suicidal tendencies.
- To investigate the influence of genetic polymorphisms on antidepressant therapy efficacy.
Summary:
- The paper details serotonin synthesis from tryptophan via hydroxylation and decarboxylation, highlighting the TPH gene's involvement.
- It examines research on TPH alleles, suicidal tendencies, and behavioral influences, noting research inconsistencies.
- The role of hydroxyindole acetic acid and serotonin transporter gene polymorphism in depression pathogenesis and treatment response is discussed.
Impact:
- Understanding the genetic underpinnings of serotonin metabolism can inform diagnostic and therapeutic strategies for depression.
- Identifying TPH gene variants may predict individual responses to antidepressant medications.
- This research contributes to the field of psychiatric genetics, emphasizing the interplay between genes, neurotransmitters, and mental health outcomes.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...